Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
August 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology
Genetic Abnormality Pinpointed for Intensive Therapy in Wilms Tumor
Phoebe Starr
Read More
Urine Biopsies Detect Early Mutations in Patients with Advanced Cancers
Wayne Kuznar
Read More
Leukemia
,
Oncology
Adding Ibrutinib to Standard Therapy Reduces Disease Progression by 80% in Previously Treated Patients with CLL
Phoebe Starr
Read More
Leukemia
,
Oncology
Adherence to Ibrutinib Therapy Improves Outcomes in Patients with CLL
Laura Morgan
Read More
Immunotherapy
,
Oncology
Immunotherapies Steal the Show at ASCO 2015
Chase Doyle
Read More
Immunotherapy
,
Oncology
Combination Immunotherapy Superior to Monotherapy in Patients with Melanoma
Chase Doyle
Read More
Arming Providers and Payers with Treatment- and Value-Based Management Tools for Battling Cancer
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
1
2
3
4
Page 4 of 4
Results 31 - 37 of 37